Antimicrobial agent | MSSA | MRSA | E. coli | E. coli ESBLs | K. pneumonia | K. pneumonia ESBLs | S. pneumonia | P. aeruginosa |
---|---|---|---|---|---|---|---|---|
Penicillin (10 U) | 81.5% | 100% | – | – | – | – | 29.0% | – |
Piperacillin (100μg) | – | – | 59.0% | 91.7% | 24.2% | 100% | – | 21.7% |
Ampicillin (10μg) | – | – | 71.4% | 100% | 100% | 100% | – | – |
Erythromycin (15μg) | 29.6% | 81.8% | – | – | – | – | 96.7% | – |
Azithromycin (15μg) | 22.2% | 83.3% | – | – | – | – | – | – |
Clarithromycin (15μg) | 34.5% | 82.8% | – | – | – | – | 93.3% | – |
Ofloxacin (5μg) | 61.2% | 6.5% | 15.6% | 26.9% | 3.7% | 3.6% | 3.2% | 10.0% |
Gentamicin (10μg) | 4.2% | 9.4% | 36.0% | 43.5% | 13.8% | 13.8% | – | 13.6% |
Co-trimoxazole (1.25/23.75μg) | 4.0% | 13.3% | 48.1% | 70.8% | 75.0% | 82.1% | 90.0% | – |
Cefazolin (30μg) | 0.0% | 100% | 32.3% | 95.7% | 36.4% | 93.5% | – | – |
Cefuroxime (30μg) | – | 100% | 24.3% | 100% | 12.9% | 97.1% | – | – |
Ceftriaxone (30μg) | – | – | 20.0% | 96.4% | 10.0% | 94.1% | 7.1% | – |
Ceftazidime (30μg) | – | – | 2.9% | 12.5% | 11.1% | 67.7% | – | 13.6% |
Cefotaxime (30μg) | – | – | 16.2% | 93.1% | 13.3% | 94.1% | 10.0% | – |
Cefepime (30μg) | – | – | 7.7% | 29.6% | 0.0% | 44.1% | 4.2% | 4.3% |
Vancomycin (30μg) | 0.0% | 0.0% | – | – | – | – | 0.0% | – |
Imipenem (10μg) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |